ProQR Therapeutics NV Sustainability Reports
ProQR Therapeutics N.V. is a biopharmaceutical company dedicated to the discovery and development of novel RNA therapies. The company leverages its proprietary Axiomer RNA editing technology platform to target genetic rare and prevalent diseases.
Sector: Professional & technical services
Country: Netherlands
Exchange: Nasdaq
LEI: 549300NGS2FJGGDBGS06
FIGI: BBG006N8B849
12 reports from 2014 to 2025
